Funnelfeedr Logo

DiaBridge AB

Sverige556979-7995Active

Developing breakthrough drugs targeting DNA repair for cancer and inflammation.

Biotechnology/Pharmaceutical Companyoxcia.com

Oversigt

0
Medarbejdere
0 SEK
Omsætning
2014
Grundlagt

Nøglebeslutningstagere

Ulrika Warpman Berglund

CEO

@oxcia.com+46732XXXXXX

Monika Vedin

Business strategy & Communication Director

@oxcia.com

Christina Kalderén

Preclinical Director

@oxcia.com

Austin Smith

Chief Medical Officer

@oxcia.com

+5 flere kontakter i Funnelfeedr

Beskrivelse

Oxcia AB is a science-led Swedish biotechnology company focused on revolutionizing treatments for cancer and inflammation. The core of their innovation lies in the unique O2-DDR technology platform, which manages oxidative stress, oxidative DNA damage, and the DNA Damage Response (DDR) in cells. Thi...

Tags

B2BPharmaceuticalsProfessional ServicesTechnologyWhite Collar

Nøgleord

BiotechClinical DevelopmentDDRDrug DiscoveryFibrosisOncologyOxidative Stress

Teknologistak

jQueryVimeoWordPressCookiebotYouTubeGoogle Analytics

Virksomhedsoplysninger

Branche
Annan naturvetenskaplig och teknisk forskning och utveckling
Juridisk form
Aktiebolag
Momsnummer
SE556979799501

Beslutningstagere

9 kontakter i Funnelfeedr

Ulrika Warpman Berglund

CEO

@oxcia.com+46732XXXXXX

Monika Vedin

Business strategy & Communication Director

@oxcia.com

Christina Kalderén

Preclinical Director

@oxcia.com

Austin Smith

Chief Medical Officer

@oxcia.com

Ingvar Karlsson

Member of the Board

@oxcia.com

Thomas Helleday

Member of the Board

@oxcia.com

Eva Sjökvist Saers

Chairman of the board

@saers.com

Håkan Nordlander

Head Administration and Accounting

@oxcia.com

Gustaf Eriksson

Sales and Marketing Manager

@atek.nu+46708XXXXXX

Lignende virksomheder

20 lignende virksomheder i Funnelfeedr

Udforsk mere

Spørgsmål om DiaBridge AB

Vil du se Funnelfeedr i aktion?

Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.

Book en demo